GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neovasc Inc (NAS:NVCN) » Definitions » Gross Profit

Neovasc (Neovasc) Gross Profit : $3.03 Mil (TTM As of Dec. 2022)


View and export this data going back to 2008. Start your Free Trial

What is Neovasc Gross Profit?

Neovasc's gross profit for the three months ended in Dec. 2022 was $1.19 Mil. Neovasc's gross profit for the trailing twelve months (TTM) ended in Dec. 2022 was $3.03 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Neovasc's gross profit for the three months ended in Dec. 2022 was $1.19 Mil. Neovasc's Revenue for the three months ended in Dec. 2022 was $1.45 Mil. Therefore, Neovasc's Gross Margin % for the quarter that ended in Dec. 2022 was 82.11%.

Neovasc had a gross margin of 82.11% for the quarter that ended in Dec. 2022 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Neovasc was 79.66%. The lowest was 25.45%. And the median was 58.46%.


Neovasc Gross Profit Historical Data

The historical data trend for Neovasc's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neovasc Gross Profit Chart

Neovasc Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.38 1.63 1.51 1.99 3.03

Neovasc Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.47 0.66 0.70 1.19

Competitive Comparison of Neovasc's Gross Profit

For the Medical Devices subindustry, Neovasc's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neovasc's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Neovasc's Gross Profit distribution charts can be found below:

* The bar in red indicates where Neovasc's Gross Profit falls into.



Neovasc Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Neovasc's Gross Profit for the fiscal year that ended in Dec. 2022 is calculated as

Gross Profit (A: Dec. 2022 )=Revenue - Cost of Goods Sold
=3.805 - 0.774
=3.03

Neovasc's Gross Profit for the quarter that ended in Dec. 2022 is calculated as

Gross Profit (Q: Dec. 2022 )=Revenue - Cost of Goods Sold
=1.453 - 0.26
=1.19

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.03 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Neovasc's Gross Margin % for the quarter that ended in Dec. 2022 is calculated as

Gross Margin % (Q: Dec. 2022 )=Gross Profit (Q: Dec. 2022 ) / Revenue (Q: Dec. 2022 )
=(Revenue - Cost of Goods Sold) / Revenue
=1.19 / 1.453
=82.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Neovasc  (NAS:NVCN) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Neovasc had a gross margin of 82.11% for the quarter that ended in Dec. 2022 => Durable competitive advantage


Neovasc Gross Profit Related Terms

Thank you for viewing the detailed overview of Neovasc's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Neovasc (Neovasc) Business Description

Traded in Other Exchanges
N/A
Address
13562 Maycrest Way, Suite 5138, Richmond, BC, CAN, V6V 2J7
Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.